MBC BioLabs AI Discovery Platforms Innovation Forum

Join us for our final Innovation Forum of 2026, spotlighting startups building AI-native platforms for discovery. Teams pairing generative models with high-throughput experimental science to design better proteins, molecules, and therapeutics, and to reach targets long considered undruggable. The MBC BioLabs AI Discovery Platform Innovation Forum brings together the founders, executives, and investors shaping AI's role in biotech. Across our ecosystem, these platforms are advancing everything from de novo protein and antibody design to precision enzymes, each grounded in the tight loop between computational design and experimental validation. Presenting startups include:

• Diffuse Bio: Building generative AI for protein therapeutics
• Birdwood Therapeutics: Enabling high-throughput, high-fidelity measurements of biological interactions, for their foundation model to understand biophysical interactions
• Integrated Biosciences: Developing multimodal aging datasets and AI-driven drug discovery for age-related disease
• Escalante: Designing AI models that predict how cells respond to therapeutic perturbations
• Post Translational Medicines: Pioneering the discovery and therapeutic targeting of disease-associated proteoforms
• Acrobat: Building the functional data layer for AI-driven protein and genome engineering
• Kerna Labs: Leveraging AI and high-throughput biology to build foundation model for mRNA therapeutics
• Onava: Bringing together biology with artificial and human intelligence for next-generation therapeutics Poster presenters: DeepSeq.AI, Therna Biosciences, Mivax Therapeutics, Lagomics, Neomera BioLab, Marwell Bio, and Ligo Bio. This is an invitation-only gathering of a thoughtfully curated group: investors, business development teams, and founders working at the frontier of the field. Expect meaningful new connections and a close look at the science and companies defining what comes next. Agenda, speakers, and further details to follow.